Riesgo de infarto de miocardio en pacientes con artrosis y espondiloartritis en tratamiento con anti-inflamatorios no esteroideos
ISSN: 2171-9020
Year of publication: 2018
Issue Title: ¿Puede la erradicación de H pylori prevenir el cáncer gástrico?
Volume: 1
Issue: 39
Type: Article
More publications in: MPG Journal
Abstract
Spondyloarthritis (SpA) is associated with an increased risk of myocardial infarction (MI) due to underlying inflammation and possibly due to medications such as certain non-steroidal anti-inflammatory drugs (NSAIDs). We sought to describe MI risk among patients with SpA who were prescribed NSAIDs, and to compare the pattern of risk in SpA with that in osteoarthritis (OA).
Bibliographic References
- Angeletti C, Guetti C, Piroli A, Angeletti PM, Paladini A, Ciccozzi A, et al. Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia. Pain Pract. 2013;13(8):657-62.
- Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70(6):896-904.
- Dale R, Stacey B. Multimodal Treatment of Chronic Pain. Med Clin North Am. 2016;100(1):55-64.
- Pergolizzi J, Alegre C, Blake D, Alen JC, Caporali R, Casser HR, et al. Current considerations for the treatment of severe chronic pain: the potential for tapentadol. Pain Pract. 2012;12(4):290-306.
- Seideman P. Additive effect of combined naproxen and paracetamol in rheumatoid arthritis. Br J Rheumatol. 1993;32(12):1077-82.
- White L, An GH, VlokR. Multimodal analgesia to reduce NSAID induced myocardial Infarction. Ann Rheum Dis. 2018.
- White LD, Hodge A, Vlok R, Hurtado G, Eastern K, Melhuish TM. Efficacy and adverse effects of buprenorphine in acute pain management: systematic review and meta-analysis of randomised controlled trials. Br J Anaesth. 2018;120(4):668-78.